The Endophthalmitis Vitrectomy Study.
Haimann
M H
MH
Weiss
H
H
Miller
J
J
D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002387:Cataract Extraction / Q000009:adverse effects; D002442:Ceftazidime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D009877:Endophthalmitis / Q000382:microbiology / Q000628:therapy*; D015818:Eye Infections, Bacterial / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007910:Lenses, Intraocular / Q000009:adverse effects; D014821:Vitrectomy
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000583:Amikacin; D002442:Ceftazidime